A federal appeals court on Wednesday wiped away a lower court's ruling that would've taken the medication abortion drug mifepristone off the market, but upheld aspects of the ruling that could cut back access to the pills.

The 5th US Circuit Court of Appeals ruling will not affect the current availability of mifepristone, as the Supreme Court has already said that the drug and regulations that make it accessible will remain in place for the time being.

This story is breaking and will be updated.